More on ZTS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $72.97 |
|
|||
| Open | $73.75 | ||||
| 52 Wk High | $53.14 | ||||
| 52 Wk Low | $38.26 | ||||
| Day High | $74.34 | ||||
| Day Low | $72.88 | ||||
| P/E | 73.43 | ||||
| EPS | $1.01 | ||||
| Volume | 2,006,773 | ||||
- Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
- FDA grants emergency use for Simparica TRIO to treat screwworm in dogs
- FDA: issues Emergency Use Authorization for Simparica Trio to treat new world screwworm in dogs & puppies
- Form 4 Zoetis Inc. For: Aug 07 Filed by: DAMELIO FRANK A
- Zoetis Inc. (ZTS) PT Lowered to $80 at UBS
- Zoetis Inc. (ZTS) PT Lowered to $115 at JPMorgan
- Form 8-K Zoetis Inc. For: Aug 06
- Form 10-Q Zoetis Inc. For: Jun 30
- William Blair Downgrades Zoetis Inc. (ZTS) to Market Perform, 'Changing Commercial Strategies Create Too Much Uncertainty on the P&L'
- Form 8-K Zoetis Inc. For: Aug 06
Entities mentioned with ZTS
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- Pershing Square Capital | View Related Stories »
- Show More...
